Sandra Levy
ARTICLES BY THIS AUTHOR
- 9/24/2020
Vertex obtains FDA blessing for new Kalydeco indication
Vertex's Kalydeco, which was first approved in 2012, has received the FDA nod for an expanded indication that will provide a Cystic Fibrosis treatment for children ages four months to less than six months old. - 9/24/2020
FDA finalizes rule for Canadian drug importation
As part of the President’s plan, on Thursday, HHS issued a final rule to implement a provision of the Federal Food, Drug, and Cosmetic Act to allow the importation of certain prescription drugs from Canada. - 9/23/2020
Bausch Health, Alfasigma resolve Xifaxan litigation with Sun Pharma
Salix will maintain market exclusivity for Xifaxan (rifaximin) 200 mg and 550 mg tablets until 2028. - 9/23/2020
Auxo acquires Euclid Medical
Auxo is making a foray into pharmaceutical packaging with the acquisition of Euclid Medical’s Precision Products Group brand. - 9/23/2020
Camber intros generic Tecfidera
Camber's generic Tecfidera provides a treatment for relapsing forms of multiple sclerosis. - 9/22/2020
NACDS supports March of Dimes’ #BlanketChange movement
The National Association of Chain Drug Stores is joining the March of Dimes’ #BlanketChange campaign to raise awareness of and eliminate racial and health disparities. - 9/22/2020
ValuCare Center is Health Mart’s Pharmacy of the Year
ValuCare Center received Health Mart’s top honor for its superior clinical performance, high-touch patient relationships and proactive advocacy efforts. - 9/21/2020
FDA letter sets back Hikma's generic Advair Diskus
Hikma said it now expects to receive FDA approval for its generic Advair Diskus in early 2021. - 9/21/2020
Zydus Cadila obtains FDA green light for generic K-Dur
Zydus Cadila’s generic K-Dur will be available in dosage strengths of 750 mg and 1,500 mg. - 9/21/2020
AllianceRx Walgreens Prime offers self-serve digital clinical assessments
More than 80% of AllianceRx Walgreens Prime’s specialty patients are eligible to complete clinical assessments online.
